News

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
19.03.2025 • News • Innovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
12.03.2025 • News

BASF Signs Offtake Agreement with Braven for Recycled Feedstock

BASF and Braven Environmental, a market leader in advanced recycling, have signed a supply agreement for Braven PyChem. This recycled feedstock, derived from mixed plastic waste, will partially replace fossil resources at the BASF TotalEnergies Petrochemical (BTP) facility in Port Arthur, Texas, US, the companies said. Under the agreement, Braven will supply BASF from a multi-unit facility that it plans to build in Texarkana, Texas.

Photo
11.03.2025 • News

Sun Pharma to Acquire Checkpoint Therapeutics

Indian generic drug maker Sun Pharma agreed to acquire US immunotherapy and targeted oncology company Checkpoint Therapeutics for an upfront value of $355 million. The transaction is expected to be completed in the second quarter of 2025 and is subject to customary closing conditions.

Photo
10.03.2025 • News

Axplora Expands Capabilities at Le Mans Site

Axplora, an API small molecule and ADC (antibody-drug conjugate) manufacturer, is strengthening its position in the commercial manufacturing ADCs by launching a cutting-edge payload manufacturing workshop at its Le Mans site (France).

Photo
07.03.2025 • News

Rio Tinto Completes Acquisition of Arcadium Lithium

Rio Tinto has completed the $6.7 billion acquisition of Arcadium Lithium and is now the parent company of Arcadium Lithium, which will be renamed Rio Tinto Lithium and will also include the Rincon Lithium Project.

Photo
06.03.2025 • News

CordenPharma Expands Peptide Manufacturing Platform in Switzerland

Contract development and manufacturing organization (CDMO) CordenPharma has finalized plans to establish a new peptide manufacturing facility in Switzerland located at Getec Park in Muttenz near Basel. This investment is part of the company’s growth initiatives with a more than €1 billion strategic investment in peptide development and manufacturing.

Photo
06.03.2025 • News

ADNOC and OMV to Create Global Polyolefins Group

OMV and ADNOC agreed to combine their Borealis and Borouge shareholdings into Borouge Group International. ADNOC has also signed a share purchase agreement with Nova Chemicals, an indirect wholly owned subsidiary of Mubadala Investment Company, to acquire 100% of Nova Chemicals for an enterprise value of $13.4 billion. In addition, ADNOC and OMV have agreed for Borouge Group International to take over Nova Chemicals after closing.

Photo
04.03.2025 • News

AbbVie Teams up with Gubra to Develop Obesity Treatment

The US pharmaceutical giant AbbVie and Danish biotechnology company Gubra, specializing in preclinical contract research services and peptide-based drug discovery within metabolic and fibrotic diseases, signed a license agreement to develop GUB014295, a potential best-in-class, long-acting amylin analog for the treatment of obesity.

Photo
03.03.2025 • News

Toray Opens R&D Center in Taiwan for Semiconductors

Toray Industries has opened the Toray Taiwan Technical Center. This new facility aims to enhance research and development in advanced semiconductor technologies and materials, and provide technical services in the Taiwan market, which plays a significant role in the global semiconductor supply chain.

Photo
27.02.2025 • News

Anchoring Plastics as the Foundation of Industry in the EU Clean Industrial Deal

Plastics Europe strongly supports the European Commission's competitiveness and decarbonization agenda and welcomes the Clean Industrial Deal. It outlines important and welcome measures, including initiatives to reduce energy costs, cut red tape and create the market demand needed to incentivize investment in the circular economy.

Photo
26.02.2025 • News

European Chemical Industry Becoming Extinct

Ahead of the unveiling of the EU’s Clean Industrial Deal, Ineos Chairman and CEO, Sir Jim Ratcliffe, authored an open letter to emphasize the importance of supportive political decisions and measures for the European industry. Releasing the open letter, Ineos stated: “A year on from the signing of ‘The Antwerp Declaration for a European Industrial Deal’ we have not seen the action necessary to stem the decline of European industry. Ineos has continued to invest in Europe; however, it is now an exception in a landscape of deindustrialization and closures.” Please read the complete open letter below:

Photo
26.02.2025 • News

Granules India Buys Swiss CDMO Senn Chemicals

Indian pharmaceutical company Granules India has agreed to acquire Senn Chemicals, a Swiss-based contract development and manufacturing organization (CDMO) specializing in peptides. The closing of the deal, which is subject to certain conditions, is expected to occur in the first half of 2025. Financial details of the transaction were not disclosed.

Photo
25.02.2025 • News

Air Products to Exit Three US-Based Projects

As part of a review initiated by Air Products’ newly-elected board of directors and CEO, the company decided to exit three projects in the US. As a result, Air Products expects to record a pre-tax charge not to exceed $3.1 billion in its fiscal 2025 second quarter, primarily to write down assets and terminate contractual commitments.

Photo
25.02.2025 • News

Symrise and Hofseth BioCare Partner on Marine Ingredients

German flavor and fragrance company Symrise has signed a strategic partnership with Hofseth BioCare (HBC), a Norwegian manufacturer of salmon-based ingredients for the human health and pet nutrition markets. With this partnership, Symrise wants to expand its presence in the health sector with clinically proven marine ingredients, the company said.

Photo
24.02.2025 • News

Nouryon Doubles Capacity of Chromatography Media in Sweden

Nouryon plans to expand its chromatography media manufacturing facility in Bohus, Sweden, doubling the site’s capacity. Construction will begin in early 2025, and the start of production is expected in early 2027, the company said.

13518 more News

Top-Feature

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.